Fisher & Paykel Healthcare: Initiation of Coverage- How Airvo 3 & Consumable Growth Fuel Explosive Revenue Potential!

Fisher & Paykel Healthcare’s recent financial results for the fiscal year ending March 31, 2025, reveal a balanced mix of robust growth and strategic challenges, providing a comprehensive overview of the company’s current performance and future outlook. On the positive front, the company reported operating revenue of $2.02 billion, marking a 16% increase from the previous year. This growth is primarily driven by broad-based expansion across its hospital consumables portfolio and significant contributions from the obstructive sleep apnea (OSA) masks. The net profit after tax achieved a 43% increase to $377.2 million, reflecting ongoing strength in their core business segments. Their hospital operating revenue rose to $1.28 billion, showing an 18% growth, attributed to solid performance in noninvasive ventilation products, including Optiflow for respiratory and anesthesia patients.